earnings
confidence high
sentiment negative
materiality 0.65
Cross Country Healthcare Q3 revenue $250M, down 21% YoY; net loss $4.8M
CROSS COUNTRY HEALTHCARE INC
2025-Q3 EPS reported
-$0.37
revenue$817,532,000
- Revenue $250.1M, down 21% YoY and 9% sequentially; gross margin 20.4% flat.
- Net loss $4.8M vs $1.2M in Q3 2024; diluted EPS ($0.15) vs ($0.23) prior year.
- Adjusted EBITDA $6.5M, down 37% YoY; adjusted EPS $0.03 vs ($0.09) a year ago.
- Cash from operations $20.1M, up 169% YoY and 377% sequentially.